Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

85.19
-1.1300-1.31%
Volume:3.08M
Turnover:263.04M
Market Cap:49.12B
PE:49.56
High:86.84
Open:85.99
Low:84.49
Close:86.32
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:0.81
T/O Rate:0.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.63
PE(LYR):46.48

Loading ...

Edwards Lifesciences upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
Jul 24

Edwards Lifesciences Corp : Leerink Partners Raises to Outperform from Market Perform; Raises Target Price to $101 from $87

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Holding Lifts Carvolix Stake to 11.65% of Capital, 9.07% Voting Rights

Reuters
·
Jul 24

Movement Alert|Edwards Lifesciences Overnight Rise 5.57%, Q2 Earnings Beat Expectations With TAVR Growth Guidance Raised

Market Focus
·
Jul 24

U.S. Research Roundup-deckers Brands, Rollins, United Rentals

Reuters
·
Jul 24

Stock Track | Edwards Lifesciences Soars 5.76% in 24-Hour Trading on Q2 Earnings Beat, Raised Guidance, and Strong Heart-Device Demand

Stock Track
·
Jul 24

American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday

Benzinga Earnings
·
Jul 24

Edwards Lifesciences Corp : JP Morgan Raises Target Price to $105 from $100

THOMSON REUTERS
·
Jul 24

Dow Jones Top Company Headlines at 9 PM ET: Intel Shares Rise as Sales Surge 25% in Second Quarter | HSBC ...

Dow Jones
·
Jul 24

Stocks to Watch: Intel, Deckers, Edwards Lifesciences, Genmab

Dow Jones
·
Jul 24

Edwards Lifesciences Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 24

Edwards Lifesciences Beats Quarterly Estimates on Strong Demand for Heart Devices

Reuters
·
Jul 24

Edwards Lifesciences Narrows Full-year Sales Outlook After 2Q Growth

Dow Jones
·
Jul 24

Edwards Lifesciences Q2 FY26 EPS Drops to $0.42; Net Sales Rise 13.6% to $1.74 Billion

Reuters
·
Jul 24

Stock Track | Edwards Lifesciences Soars 7.37% in After-Hours Trading on Q2 Earnings Beat and Reaffirmed Guidance

Stock Track
·
Jul 24

Edwards Lifesciences Q2 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $1.741B Beat $1.700B Estimate

Benzinga Earnings
·
Jul 24

Edwards Lifesciences Q2 Sales USD 1,741 Million VS. Ibes Estimate USD 1,700 Million

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Corp - Expects 2026 Sales of $6.6-$6.90 Bln

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Outlook Q3 Adjusted EPS USD 0.71-0.77

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Corp - Reaffirms 2026 Adj EPS Guidance of $2.95-$3.05

THOMSON REUTERS
·
Jul 24